RRML - Ischemic modified albumin increases in acute kidney injury
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- September 2018 -
 
Rationale and Design of a Pros... 12
Biomarkers in heart failure: f... 11
Romanian Review of Laboratory ... 9
Postoperative interleukin-8 le... 8
Serum hs-CRP, YKL-40 and brain... 6
Biomarkers in Obesity... 6
Phenotypic and molecular ident... 5
Plasma phosphorylated neurofil... 4
Antibiotic susceptibility and ... 4
Candida albicans isolates from... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(1)/2018 DOI:10.2478/rrlm-2018-0002
XML
TXT

Research article

Ischemic modified albumin increases in acute kidney injury

Cuma Mertoglu, Murat Gunay, Ali Gurel, Mehmet Gungor, Vahdet Gul

Correspondence should be addressed to: Cuma Mertoglu

Abstract:

Purpose: Acute kidney injury (AKI) is a severe kidney disease carrying high morbidity and mortality. An ischemic process, at the cellular level, has been detected prior to the full-blown AKI. An elevated ischemic modified albumin (IMA) was also found to be increased fast at several minutes following an ischemic process in the body. In this connection, we have investigated, in advance, the changes of IMA concentrations in patients with possible AKI. Methods: IMA and other biochemical and haematological parameters were measured in sera of thirty nine patients with AKI and of thirty eight healthy controls. AKI is defined by an increase in serum creatinine by ≥ 0.3 mg/dl in 48 hours or an increase by ≥ 1.5-fold from a known or assumed baseline. The results in the two groups were compared. Results: IMA, creatinine, blood urea nitrogen, white blood cell, neutrophil, neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) and mean platelet volume were found to be higher in patients with AKI than in healthy controls. In contrast, total protein, albumin, lymphocyte, and haemoglobin were lower in patients with AKI than in healthy controls. No significant difference was recorded in platelet counts between the two groups. Conclusion: Our results indicate that increased levels of NLR and PLR play a central role in a systemic inflammation in AKI. Monitoring serum IMA could be a useful tool in the assessment of AKI.

Keywords: Acute kidney injury, ischemic modified albumin, neutrophil–lymphocyte ratio, platelet–lymphocyte ratio, mean platelet volume

Received: 23.5.2017
Accepted: 19.11.2017
Published: 16.12.2017

 
  PDF Download full text PDF
(366 KB)
     
 
How to cite
Mertoglu C, Gunay M, Gurel A, Gungor M, Gul V. Ischemic modified albumin increases in acute kidney injury. Rev Romana Med Lab. 2018;26(1):37-43. DOI:10.2478/rrlm-2018-0002